| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $4.54B | -17.2% |
| Gross Profit | $1.72B | -24.0% |
| R&D Expense | $280.8M | -3.8% |
| SG&A Expense | $124.7M | -16.1% |
| Operating Income | $458.5M | -40.8% |
| Pre-tax Income | $463.5M | -40.3% |
| Income Tax | $98.9M | -24.6% |
| Net Income | $364.6M | -43.4% |
| EPS (Basic) | $2.25 |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.15B | -13.5% |
| Accounts Receivable | $630.4M | -6.7% |
| Inventory | $682.9M | -26.8% |
| Current Assets | $2.61B | -15.2% |
| Total Assets | $3.56B | -11.8% |
| Current Liabilities | $1.05B | -26.1% |
| Total Liabilities | $1.30B | -20.4% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $534.0M | +79.0% |
| Capital Expenditures | $92.4M | +3.6% |
| Investing Cash Flow | -$105.7M | +2.0% |
| Financing Cash Flow | -$583.4M | +3.9% |
| Free Cash Flow | $441.7M | +111.2% |
| -41.6% |
| EPS (Diluted) | $2.23 | -41.0% |
| Stockholders' Equity |
| $2.26B |
| -5.9% |